{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:46:28Z","timestamp":1792269988496,"version":"4.4.0"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T00:00:00Z","timestamp":1663891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100007048","name":"Mayo Foundation for Medical Education and Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Avascular necrosis (AVN) is a known adverse event associated with corticosteroid (CS) usage. Inflammatory bowel disease (IBD) is often treated with a CS for induction of remission. We sought to describe clinical features and outcomes of IBD patients with AVN.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this retrospective, single-center, case-control study, patients with IBD who had a diagnosis of osteonecrosis, aseptic necrosis, or AVN from 1976 to 2009 were included, and each was matched with up to 2 controls (IBD but no AVN) on age, sex, IBD subtype, geographic area of residence, and date of IBD diagnosis. We abstracted risk factor data from the medical records. Conditional logistic regression was performed accounting for minor differences in age and date of first IBD visit to assess the relationship between putative risk factors and AVN, expressed as odds ratio and 95% confidence interval.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Eighty-five patients were diagnosed with IBD-AVN and were matched with 163 controls. The mean age at AVN diagnosis was 47.5 years. AVN was diagnosed a median of 12.2 years after IBD diagnosis, and the control group was followed for a median of 15 years after IBD diagnosis to ensure that they did not have AVN. Ten percent of patients with AVN did not have any CS exposure. History of arthropathy or estrogen use in Crohn\u2019s disease and use of CS, osteoporosis, and history of arthropathy in ulcerative colitis were significantly associated with AVN.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Most patients with IBD-AVN had multifocal involvement. Most had received CS, but many patients had other risk factors including arthropathy.<\/jats:p><\/jats:sec>","DOI":"10.1093\/ibd\/izac198","type":"journal-article","created":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T19:22:34Z","timestamp":1663960954000},"page":"1223-1230","source":"Crossref","is-referenced-by-count":9,"title":["Osteonecrosis in Inflammatory Bowel Disease: Clinical Features, Risk Factor Analysis, and Outcomes"],"prefix":"10.1093","volume":"29","author":[{"given":"Zeinab","family":"Bakhshi","sequence":"first","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Mayo Clinic , Rochester, MN , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddhant","family":"Yadav","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, Mayo Clinic , Rochester, MN , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W Scott","family":"Harmsen","sequence":"additional","affiliation":[{"name":"Division of Clinical Trials and Biostatistics, Mayo Clinic , Rochester, MN , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jithinraj","family":"Edakkanambeth Varayil","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, Mayo Clinic , Rochester, MN , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin A","family":"Karls","sequence":"additional","affiliation":[{"name":"St. Alexius Medical Center , Bismarck, ND , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J","family":"Tremaine","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Mayo Clinic , Rochester, MN , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7199-6851","authenticated-orcid":false,"suffix":"Jr","given":"Edward V","family":"Loftus","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Mayo Clinic , Rochester, MN , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,9,23]]},"reference":[{"issue":"2","key":"2023080117151851900_CIT0001","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1053\/sarh.2002.33724b","article-title":"Pathogenesis and natural history of osteonecrosis","volume":"32","author":"Assouline-Dayan","year":"2002","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"2023080117151851900_CIT0002","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1056\/NEJMcp1012926","article-title":"Glucocorticoid-induced bone disease","volume":"365","author":"Weinstein","year":"2011","journal-title":"N Engl J Med."},{"issue":"7","key":"2023080117151851900_CIT0003","doi-asserted-by":"crossref","first-page":"e016788","DOI":"10.1136\/bmjopen-2017-016788","article-title":"Oral glucocorticoid use and osteonecrosis in children and adults with chronic inflammatory diseases: a population-based cohort study","volume":"7","author":"Horton","year":"2017","journal-title":"BMJ Open"},{"issue":"5","key":"2023080117151851900_CIT0004","doi-asserted-by":"crossref","first-page":"834","DOI":"10.2106\/00004623-200205000-00023","article-title":"Osteonecrosis of the hip: management in the twenty-first century","volume":"84","author":"Lieberman","year":"2002","journal-title":"J Bone Joint Surg."},{"key":"2023080117151851900_CIT0005","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2174\/1874325000903010027","article-title":"Joint arthroplasties other than the hip in solid organ transplant recipients","volume":"3","author":"Sayed-Noor","year":"2009","journal-title":"Open Orthop J."},{"issue":"8","key":"2023080117151851900_CIT0006","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1002\/1529-0131(200008)43:8<1801::AID-ANR16>3.0.CO;2-O","article-title":"Damage in systemic lupus erythematosus and its association with corticosteroids","volume":"43","author":"Zonana-Nacach","year":"2000","journal-title":"Arthritis Rheum."},{"issue":"4","key":"2023080117151851900_CIT0007","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1177\/112070001002000410","article-title":"Avascular necrosis of the femoral head in patients with Hodgkin\u2019s disease","volume":"20","author":"Renedo","year":"2010","journal-title":"Hip Int."},{"issue":"1","key":"2023080117151851900_CIT0008","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/RHU.0000000000000797","article-title":"Prevalence and associations of avascular necrosis of the hip in a large well-characterized cohort of patients with inflammatory bowel disease","volume":"25","author":"Rolston","year":"2019","journal-title":"J Clin Rheum"},{"issue":"2","key":"2023080117151851900_CIT0009","first-page":"138","article-title":"Prevalence rates and an evaluation of reported risk factors for osteonecrosis (avascular necrosis) in Crohn\u2019s disease","volume":"14","author":"Freeman","year":"2000","journal-title":"Can J Gastroenterol Hepatol."},{"issue":"3-5","key":"2023080117151851900_CIT0010","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jsbmb.2009.02.007","article-title":"Glucocorticoids in osteonecrosis of the femoral head: a new understanding of the mechanisms of action","volume":"114","author":"Kerachian","year":"2009","journal-title":"J Steroid Biochem Mol Biol."},{"issue":"3","key":"2023080117151851900_CIT0011","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1365-2036.2007.03379.x","article-title":"Appropriate use of corticosteroids in Crohn\u2019s disease","volume":"26","author":"Irving","year":"2007","journal-title":"Aliment Pharmarcol Ther."},{"issue":"4","key":"2023080117151851900_CIT0012","doi-asserted-by":"crossref","first-page":"579","DOI":"10.4292\/wjgpt.v7.i4.579","article-title":"Osteonecrosis of both knees in a woman with Crohn\u2019s disease","volume":"7","author":"Barbosa","year":"2016","journal-title":"World J Gastrointest Pharmacol Ther."},{"issue":"7","key":"2023080117151851900_CIT0013","first-page":"601","article-title":"Osteomyelitis and osteonecrosis in inflammatory bowel disease","volume":"11","author":"Freeman","year":"1997","journal-title":"Can J Gastroenterol Hepatol."},{"key":"2023080117151851900_CIT0014","doi-asserted-by":"crossref","DOI":"10.1159\/isbn.978-1-910797-16-7","volume-title":"Fast facts: inflammatory bowel disease. Basel, Switzerland: Karger Medical and Scientific Publishers","author":"Rampton","year":"2016"},{"issue":"4","key":"2023080117151851900_CIT0015","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1148\/rg.2017160121","article-title":"Beyond the bowel: extraintestinal manifestations of inflammatory bowel disease","volume":"37","author":"Olpin","year":"2017","journal-title":"Radiographics"},{"issue":"1","key":"2023080117151851900_CIT0016","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/0016-5085(89)90764-6","article-title":"Steroid-related osteonecrosis in inflammatory bowel disease","volume":"96","author":"Vakil","year":"1989","journal-title":"Gastroenterology"},{"issue":"34-35","key":"2023080117151851900_CIT0017","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1055\/s-2005-872607","article-title":"Recurrent aseptic osteonecrosis in Crohn\u2019s disease-extraintestinal manifestation or steroid related complication?]","volume":"130","author":"Lanyi","year":"2005","journal-title":"Dtsch Med Wochenschr."},{"issue":"11","key":"2023080117151851900_CIT0018","first-page":"765","article-title":"Osteonecrosis in a patient with Crohn\u2019s disease unrelated to corticosteroid use","volume":"15","author":"Khan","year":"2001","journal-title":"Can J Gastroenterol Hepatol."},{"issue":"1","key":"2023080117151851900_CIT0019","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1302\/0301-620X.67B1.3155745","article-title":"Idiopathic bone necrosis of the femoral head. Early diagnosis and treatment","volume":"67","author":"Ficat","year":"1985","journal-title":"J Bone Joint Surg Br."},{"issue":"9","key":"2023080117151851900_CIT0020","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1007\/s11999-012-2416-2","article-title":"In brief: Ficat classification: avascular necrosis of the femoral head","volume":"470","author":"Jawad","year":"2012","journal-title":"Clin Orthop Relat Res."},{"issue":"3","key":"2023080117151851900_CIT0021","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2106\/00004623-199503000-00018","article-title":"Non-traumatic avascular necrosis of the femoral head","volume":"77","author":"Mont","year":"1995","journal-title":"J Bone Joint Surg."},{"issue":"4","key":"2023080117151851900_CIT0022","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/ajg.2018.27","article-title":"ACG clinical guideline: management of Crohn\u2019s disease in adults","volume":"113","author":"Lichtenstein","year":"2018","journal-title":"Am J Gastroenterol."},{"issue":"3","key":"2023080117151851900_CIT0023","doi-asserted-by":"crossref","first-page":"384","DOI":"10.14309\/ajg.0000000000000152","article-title":"ACG clinical guideline: ulcerative colitis in adults","volume":"114","author":"Rubin","year":"2019","journal-title":"Am J Gastroenterol."},{"issue":"2","key":"2023080117151851900_CIT0024","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1148\/radiology.179.2.2014304","article-title":"Apparent avascular necrosis of the hip: appearance and spontaneous resolution of MR findings in renal allograft recipients","volume":"179","author":"Kopecky","year":"1991","journal-title":"Radiology"},{"issue":"2","key":"2023080117151851900_CIT0025","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1302\/0301-620X.79B2.0790213","article-title":"Osteonecrosis of the femoral head: a prospective study with MRI","volume":"79","author":"Sakamoto","year":"1997","journal-title":"J Bone Joint Surg Br."},{"key":"2023080117151851900_CIT0026","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/00003086-199408000-00023","article-title":"Prognostication of osteonecrosis of the femoral head in patients with systemic lupus erythematosus by magnetic resonance imaging","volume":"305","author":"Sugano","year":"1994","journal-title":"Clin Orthop Relat Res."},{"issue":"4","key":"2023080117151851900_CIT0027","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s100670200078","article-title":"Risk period for developing osteonecrosis of the femoral head in patients on steroid treatment","volume":"21","author":"Koo","year":"2002","journal-title":"Clin Rheumatol."},{"issue":"3","key":"2023080117151851900_CIT0028","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1365-2036.2005.02231.x","article-title":"Inflammatory bowel disease related osteonecrosis: report of a large series with a review of the literature","volume":"21","author":"Klingenstein","year":"2005","journal-title":"Aliment Pharmarcol Ther."},{"issue":"1","key":"2023080117151851900_CIT0029","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1515\/med-2019-0011","article-title":"Musculoskeletal clinical and imaging manifestations in inflammatory bowel diseases","volume":"14","author":"Sarbu","year":"2019","journal-title":"Open Med (Wars)."},{"issue":"3","key":"2023080117151851900_CIT0030","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/ecco-jcc\/jjv213","article-title":"The first European evidence-based consensus on extra-intestinal manifestations in inflammatory bowel disease","volume":"10","author":"Harbord","year":"2015","journal-title":"J Crohns Colitis"},{"issue":"1","key":"2023080117151851900_CIT0031","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3748\/wjg.v20.i1.45","article-title":"Current issues in pediatric inflammatory bowel disease-associated arthropathies","volume":"20","author":"Cardile","year":"2014","journal-title":"World J Gastroenterol."},{"issue":"3","key":"2023080117151851900_CIT0032","first-page":"173","article-title":"Rheumatological manifestations in inflammatory bowel disease","volume":"24","author":"Voulgari","year":"2011","journal-title":"Ann Gastroenterol."},{"issue":"Suppl_2","key":"2023080117151851900_CIT0033","doi-asserted-by":"crossref","first-page":"S253","DOI":"10.1016\/S1590-8658(08)60534-4","article-title":"Extraintestinal manifestations of inflammatory bowel disease","volume":"40","author":"Ardizzone","year":"2008","journal-title":"Dig Liver Dis."},{"issue":"8","key":"2023080117151851900_CIT0034","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1097\/MIB.0000000000000392","article-title":"Extraintestinal manifestations of inflammatory bowel disease","volume":"21","author":"Vavricka","year":"2015","journal-title":"Inflamm Bowel Dis."},{"issue":"12","key":"2023080117151851900_CIT0035","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1080\/003655201317097173","article-title":"Musculoskeletal manifestations in a population-based cohort of inflammatory bowel disease patients","volume":"36","author":"Salvarani","year":"2001","journal-title":"Scand J Gastroenterol."},{"issue":"12","key":"2023080117151851900_CIT0036","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1080\/17512433.2017.1377609","article-title":"Management of patients with inflammatory bowel disease and spondyloarthritis","volume":"10","author":"Pouillon","year":"2017","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"9","key":"2023080117151851900_CIT0037","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/j.arth.2015.03.036","article-title":"High-dose corticosteroid use and risk of hip osteonecrosis: meta-analysis and systematic literature review","volume":"30","author":"Mont","year":"2015","journal-title":"J Arthroplasty."},{"issue":"3","key":"2023080117151851900_CIT0038","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1055\/s-0034-1365933","article-title":"A rare cause of peripheral arthralgia in inflammatory bowel disease: multifocal osteonecrosis","volume":"52","author":"Grunert","year":"2014","journal-title":"Z Gastroenterol."},{"issue":"3","key":"2023080117151851900_CIT0039","first-page":"327","article-title":"Osteonecrosis in inflammatory bowel diseases: a review of the literature","volume":"72","author":"Hauzeur","year":"2009","journal-title":"Acta Gastroenterol Belg."},{"issue":"11","key":"2023080117151851900_CIT0040","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1155\/2000\/294195","article-title":"Granulomatous osteonecrosis in Crohn\u2019s disease","volume":"14","author":"Freeman","year":"2000","journal-title":"Can J Gastroenterol Hepatol."},{"issue":"4","key":"2023080117151851900_CIT0041","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00198-009-1003-1","article-title":"The epidemiology of osteonecrosis: findings from the GPRD and THIN databases in the UK","volume":"21","author":"Cooper","year":"2010","journal-title":"Osteoporos Int."},{"key":"2023080117151851900_CIT0042","doi-asserted-by":"crossref","first-page":"4175923","DOI":"10.1155\/2019\/4175923","article-title":"Epidemiology and clinical outcomes of inflammatory bowel disease: a hospital-based study in Central Taiwan","volume":"2019","author":"Chou","year":"2019","journal-title":"Gastroenterol Res Pract."},{"issue":"3","key":"2023080117151851900_CIT0043","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s12328-008-0015-2","article-title":"Osteonecrosis of the lateral femoral condyle in a patient with ulcerative colitis: report of a case","volume":"1","author":"Takeda","year":"2008","journal-title":"Clin J Gastroenterol."}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ibdjournal\/advance-article-pdf\/doi\/10.1093\/ibd\/izac198\/45983311\/izac198.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/29\/8\/1223\/51017429\/izac198.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/29\/8\/1223\/51017429\/izac198.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T14:43:00Z","timestamp":1728052980000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article\/29\/8\/1223\/6712289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,23]]},"references-count":43,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,9,23]]},"published-print":{"date-parts":[[2023,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ibd\/izac198","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"value":"1078-0998","type":"print"},{"value":"1536-4844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,8,1]]},"published":{"date-parts":[[2022,9,23]]}}}